Lexaria Bioscience (LEXX) Cash from Financing Activities (2010 - 2026)
Lexaria Bioscience's Cash from Financing Activities came in at $3.04 million for fiscal Q2 2026 (quarter ended Feb 28, 2026), compared with $11,720 a year earlier and down 12.4% from the prior quarter.
Powered by 
Analysis
Lexaria Bioscience (LEXX) Cash from Financing Activities (2010 - 2026) Analysis & Trends
For FY2025 (ended Aug 31, 2025), Lexaria Bioscience's Cash from Financing Activities was $6.05 million, down 41.4% from FY2024.
- Cash from Financing Activities carries a five-year compound annual growth rate of 17.9% (FY2020 to FY2025).
- Going back by fiscal year, Cash from Financing Activities was $10.32 million in FY2024 (+548.9%), $1.59 million in FY2023, -$44,600 in FY2022 and $13.42 million in FY2021 (+405.6%).
- The five-year range for quarterly Cash from Financing Activities is -$121,687 (fiscal Q4 2023) to $5.04 million (fiscal Q3 2024).
- Year-over-year, Cash from Financing Activities increased in two of the last five quarters, with growth averaging 29.5%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Lexaria Bioscience | 3.26 Mn | -12.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Feb 28, 2026 | 3.04 Mn |
| Nov 30, 2025 | 3.47 Mn |
| May 31, 2025 | 1.69 Mn |
| Feb 28, 2025 | 11,720.00 |
| Nov 30, 2024 | 4.35 Mn |
| May 31, 2024 | 5.04 Mn |
| Feb 29, 2024 | 3.45 Mn |
| Nov 30, 2023 | 1.82 Mn |
| Aug 31, 2023 | -121,687.00 |
| May 31, 2023 | 1.71 Mn |
| Aug 31, 2022 | -11,205.00 |
| May 31, 2022 | -11,204.00 |
| Feb 28, 2022 | -11,204.00 |
| Nov 30, 2021 | -10,987.00 |
| Aug 31, 2021 | 4.00 Mn |
| May 31, 2021 | -10,987.00 |
| Feb 28, 2021 | 9.44 Mn |
| Nov 30, 2020 | -8,767.00 |
| Aug 31, 2020 | -89,153.00 |
| May 31, 2020 | 1.92 Mn |
API Access
Lexaria Bioscience Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=LEXX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();